Manipal Health Enterprises shares list at 11% premium over IPO price on BSE, NSE
Manipal Health Enterprises shares debuted on Wednesday with an 11% premium. The IPO garnered strong demand, especially from institutional investors. The company plans to use IPO proceeds for debt repayment and acquisitions. Manipal Health Enterpri...
By Ritesh Presswala, ETMarkets.com | Updated:
BCCL
Shares of Manipal Health Enterprises listed at 11% premium over IPO price on Wednesday. The stock opened at Rs 655 and Rs 652 on BSE and NSE, as compared to its issue price of Rs 590.
The IPO, which was open for subscription from July 29 to July 31, garnered an overall subscription of 4.92 times. The issue saw strong demand from institutional investors, with the Qualified Institutional Buyers (QIB) segment subscribed 8.25 times.
Interest from Non-Institutional Investors (NIIs) remained moderate, with the category subscribed 1.02 times, while the Retail Individual Investor (RII) portion was subscribed 93%.
The public issue comprised a fresh issue of 13.56 crore equity shares worth Rs 8,000 crore and an Offer for Sale (OFS) of 2.16 crore shares valued at Rs 1,275.22 crore, taking the total issue size to Rs 9,275.22 crore.
The IPO was priced in the Rs 560–Rs 590 per share band. Kotak Mahindra Capital acted as the book-running lead manager for the issue, while KFin Technologies served as the registrar.
Read More: Ola Electric Mobility shares rally over 7%. What's boosting investor sentiment?
The company provides advanced tertiary and quaternary healthcare services across key specialties, including oncology, cardiology, neurology, orthopaedics, organ transplantation and preventive healthcare.
As of March 31, 2026, Manipal Health Enterprises operated 49 hospitals with 13,037 licensed beds and 21 clinics across India. The organisation has a workforce of more than 24,000 employees, including over 11,000 nurses and 6,300 paramedics.
Over the years, the healthcare chain has expanded through acquisitions, investments in medical infrastructure and increased adoption of digital healthcare solutions.
Read More: Rupee sails past 95 to one-month high, premiums drop before RBI decision
The company has earmarked Rs 5,378 crore for debt repayment, a move aimed at lowering borrowing costs and improving its financial position. Additionally, Rs 574 crore will be used to acquire a minority stake in its step-down subsidiary, Sahyadri Hospitals.
The remaining proceeds will be deployed for general corporate purposes and to fund future business expansion.
As one of India's largest hospital operators, Manipal Health Enterprises' market debut will be closely tracked by investors for cues on sentiment toward the country's fast-growing healthcare sector.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
The IPO, which was open for subscription from July 29 to July 31, garnered an overall subscription of 4.92 times. The issue saw strong demand from institutional investors, with the Qualified Institutional Buyers (QIB) segment subscribed 8.25 times.
Interest from Non-Institutional Investors (NIIs) remained moderate, with the category subscribed 1.02 times, while the Retail Individual Investor (RII) portion was subscribed 93%.
The public issue comprised a fresh issue of 13.56 crore equity shares worth Rs 8,000 crore and an Offer for Sale (OFS) of 2.16 crore shares valued at Rs 1,275.22 crore, taking the total issue size to Rs 9,275.22 crore.
The IPO was priced in the Rs 560–Rs 590 per share band. Kotak Mahindra Capital acted as the book-running lead manager for the issue, while KFin Technologies served as the registrar.
Read More: Ola Electric Mobility shares rally over 7%. What's boosting investor sentiment?
ADVERTISEMENT
About Manipal Health Enterprises
Founded in 2010, Manipal Health Enterprises has emerged as one of India’s leading healthcare providers, with a wide network of multi-specialty hospitals, clinics and diagnostic centres.The company provides advanced tertiary and quaternary healthcare services across key specialties, including oncology, cardiology, neurology, orthopaedics, organ transplantation and preventive healthcare.
As of March 31, 2026, Manipal Health Enterprises operated 49 hospitals with 13,037 licensed beds and 21 clinics across India. The organisation has a workforce of more than 24,000 employees, including over 11,000 nurses and 6,300 paramedics.
Over the years, the healthcare chain has expanded through acquisitions, investments in medical infrastructure and increased adoption of digital healthcare solutions.
ADVERTISEMENT
Read More: Rupee sails past 95 to one-month high, premiums drop before RBI decision
How Manipal Health Enterprises Will Use IPO Proceeds
Manipal Health Enterprises plans to use a substantial portion of the fresh issue proceeds to strengthen its balance sheet and support future growth.ADVERTISEMENT
The company has earmarked Rs 5,378 crore for debt repayment, a move aimed at lowering borrowing costs and improving its financial position. Additionally, Rs 574 crore will be used to acquire a minority stake in its step-down subsidiary, Sahyadri Hospitals.
The remaining proceeds will be deployed for general corporate purposes and to fund future business expansion.
As one of India's largest hospital operators, Manipal Health Enterprises' market debut will be closely tracked by investors for cues on sentiment toward the country's fast-growing healthcare sector.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Manipal Health Enterprises IPO listing tomorrow: Here’s what GMP indicates ahead of market debutADVERTISEMENT
